1569.7000 -11.80 (-0.75%)
NSE Dec 02, 2025 15:31 PM
Volume: 17,568
 

1569.70
-0.75%
BOB Capital Markets Ltd.
ERIS posted strong revenue performance in Q4 with a beat of 8%, but EBITDA came below BBG consensus due to higher opex and one-offs
Promoters unpledged 0.01% of shares in last quarter. Total pledge stands at 16.92% of promoter holdings
More from Eris Lifesciences Ltd.
Recommended